| Pre-MFDC | Post-MFDC | Sign. | ||||||
---|---|---|---|---|---|---|---|---|---|
2007 (n = 21) | 2008 (n = 20) | 2010 (n = 24) | 2013 (n = 24) | ANOVA | |||||
Age Mean(SD) | 66 | (11) | 66 | (13) | 63 | (13) | 64 | (9) | .640 |
 | Chi2 | ||||||||
Gender | n | % | n | % | n | % | n | % | .680 |
 Male | 14 | 67 | 13 | 65 | 18 | 75 | 14 | 58 |  |
Tumour localization | .303 | ||||||||
 Lip | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 100 |  |
 Oral cavity | 8 | 38 | 11 | 55 | 17 | 71 | 9 | 38 |  |
  Tongue (C01, C02) | 3 |  | 2 |  | 6 |  | 1 |  |  |
  Gums (C03) | 1 |  | 3 |  | 2 |  | 0 |  |  |
  Floor of mouth (C04) | 3 |  | 4 |  | 4 |  | 6 |  |  |
  Oral cavity, unspec. | 1 |  | 2 |  | 5 |  | 2 |  |  |
(C00, C05, C06, C14) | |||||||||
 Major salivary glands (C07, C08) | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |  |
 Oropharynx (C09,C10) | 2 | 10 | 2 | 10 | 1 | 4 | 4 | 17 |  |
 Nasopharynx (C11) | 1 | 5 | 2 | 10 | 1 | 4 | 1 | 4 |  |
 Nasal Cavity (C30) | 0 |  | 0 | 0 | 1 | 4 | 1 | 4 |  |
 Hypopharynx (C12, C13) | 3 | 14 | 1 | 5 | 0 | 0 | 5 | 21 |  |
 Larynx (C32) | 6 | 29 | 4 | 20 | 4 | 17 | 2 | 8 |  |
Tumour size | .522 | ||||||||
 T1 | 9 | 43 | 8 | 40 | 10 | 42 | 4 | 17 |  |
 T2 | 5 | 24 | 4 | 20 | 5 | 21 | 6 | 26 |  |
 T3 | 3 | 14 | 2 | 10 | 3 | 13 | 2 | 8 |  |
 T4 | 4 | 19 | 6 | 30 | 5 | 21 | 12 | 50 |  |
 Tx | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |  |